Skip to main content

Table 5 Multivariable HR and 95% CI between ΔLDH and OS in HCC patients treated by TACE

From: Arterial chemoembolization for patients with hepatocellular carcinoma and elevated lactate dehydrogenase is associated with low survival: a cohort study

 

ΔLDH(U/L)

> − 80, < 80

≤ − 80

≥ 80

Deaths/patients

226/444

117/217

62/88

Not adjusted

Reference

1.24 (0.99, 1.55)

2.31 (1.74, 3.06)

Model I*

Reference

1.28 (1.02, 1.60)

1.90 (1.43, 2.53)

Model II#

Reference

1.11 (0.88, 1.39)

1.40 (1.04, 1.87)

  1. Due to missing data, the total of the above data is less than 749. *The model adjusted Gender(Male, Female),PS score (0, 1), age (< 55,  ≥ 55), Child–Pugh class (A, B). #The model was adjusted based on Gender(Male, Female), PS score (0, 1), age (< 55,  ≥ 55), Child–Pugh class (A, B), location of lesions (none, left/right, both), diameter of main tumour (< 5,  ≥ 5), No. of intrahepatic lesions (0,  ≤ 3,  > 3), AFP (< 25,  ≥ 25), Hgb (g/L) (< 120,  ≥ 120) and WBC (109/L) (< 11,  ≥ 11)